Buparvaquone: Advanced Antiprotozoal Compound | Hebei Guangxing Chemical | High-Purity Synthesis

Buparvaquone is a cutting-edge antiprotozoal compound with significant applications in pharmaceutical research and development. This article provides an in-depth analysis of its chemical properties, technical specifications, and industrial relevance, supported by authoritative references and product details from Hebei Guangxing Chemical Industry Co., Ltd..

Product Overview

Buparvaquone (CAS: 88426-33-9) is a synthetic naphthoquinone derivative designed for targeted therapeutic applications. Known by alternative names such as CS-1178, BW-720C, and Butalex, this compound demonstrates unique chemical properties that make it a valuable asset in modern medicine. The illustrates its complex molecular architecture, which includes a cyclohexyl group and hydroxyl functionality.

Key Features

• High Purity: The compound is synthesized to meet stringent pharmaceutical standards, ensuring consistent performance in research and development.
• Chemical Stability: Its 2-((4-tert-butylcyclohexyl)methyl)-3-hydroxy-1,4-naphthoquinone structure provides resistance to degradation under standard storage conditions.
• Targeted Antiprotozoal Activity: Demonstrated efficacy against specific protozoan parasites, making it a critical component in developing treatments for parasitic diseases.
• Customizable Synthesis: The compound's molecular framework allows for modifications to enhance bioavailability and therapeutic outcomes.

Technical Specifications

Advantages of Buparvaquone

Buparvaquone offers several advantages that position it as a preferred choice in pharmaceutical and research applications:

• Enhanced Bioavailability: The compound's molecular design facilitates efficient absorption and distribution in biological systems.
• Reduced Toxicity: Comparative studies indicate lower cytotoxic effects on mammalian cells compared to traditional antiprotozoal agents.
• Cost-Effective Synthesis: The production process, optimized by Hebei Guangxing Chemical Industry Co., Ltd., ensures economic viability for large-scale manufacturing.
• Regulatory Compliance: Adherence to international standards for chemical safety and quality control.

Application Scenarios

Buparvaquone is utilized in diverse fields, including:

• Pharmaceutical Research: Development of novel antiprotozoal drugs for diseases like leishmaniasis and trypanosomiasis.
• Biomedical Studies: Investigation of its mechanism of action against protozoan parasites at the cellular and molecular levels.
• Chemical Synthesis: Intermediate for producing related compounds with modified pharmacological profiles.
• Industrial Applications: Quality control testing for purity and stability in chemical manufacturing processes.

Company Background: Hebei Guangxing Chemical Industry Co., Ltd.

Hebei Guangxing Chemical Industry Co., Ltd. is a leading manufacturer of specialty chemicals based in China. With decades of expertise in organic synthesis and pharmaceutical intermediates, the company has established itself as a reliable supplier of high-purity compounds like Buparvaquone. Their state-of-the-art facilities and commitment to quality assurance ensure that products meet global standards.

Scientific and Regulatory Context

While specific NIST standards for Buparvaquone could not be retrieved due to technical constraints, the compound aligns with general guidelines for antiprotozoal agents outlined by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO). For detailed analytical methods and reference materials, consult the National Institute of Standards and Technology (NIST) database.

Conclusion

Buparvaquone represents a significant advancement in antiprotozoal therapy, combining chemical innovation with practical applications. Its robust technical specifications and the expertise of Hebei Guangxing Chemical Industry Co., Ltd. make it a trusted choice for researchers and manufacturers. For more information, visit the Buparvaquone product page.

References

1. National Institute of Standards and Technology (NIST) – For chemical standards and analytical methodologies.

2. U.S. Food and Drug Administration (FDA) – Regulatory guidelines for antiprotozoal compounds.

3. World Health Organization (WHO) – Global health strategies for parasitic diseases.